Australia's Bioxyne hits nearly 8-year high on cannabis firm deal

BLS Pharmaceuticals

01/04/2026 24:45

** Bioxyne BXN.AX rises as much as 9.5% to A$0.069, highest since June 5, 2018

** Pharmaceutical firm says its unit entered into manufacturing deal with Canada-based Aurora Cannabis ACB.TO

** Adds deal covers supply of medicinal cannabis oils into Australian market

** YTD, BXN up more than 60%

 (Reporting by Rajasik Mukherjee in Bengaluru)

 ((Rajasik.Mukherjee@thomsonreuters.com))